<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04332471</url>
  </required_header>
  <id_info>
    <org_study_id>2019-1517</org_study_id>
    <nct_id>NCT04332471</nct_id>
  </id_info>
  <brief_title>Shockwave Therapy for Plantar Fasciitis RCT</brief_title>
  <official_title>Treatment of Plantar Fasciitis With Radial Shockwave Therapy vs. Focused Shockwave Therapy: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital for Special Surgery, New York</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital for Special Surgery, New York</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Inflammation of the plantar fascia is known as plantar fasciitis and is commonly seen in&#xD;
      active or overweight individuals. It can be treated via conservative or surgical therapies.&#xD;
      Extracorporeal shockwave therapy has shown promise in the treatment of plantar fasciitis.&#xD;
      Several studies have compared the effects of different types of extracorporeal shockwave&#xD;
      therapy (radial and focused) with other forms of conservative treatment in patients with&#xD;
      chronic plantar fasciitis. No study has yet compared the effect of radial vs. focused&#xD;
      shockwave therapy on pain in this population.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Plantar fasciitis is a common foot problem that affects 3.8 per 1,000 persons in the United&#xD;
      States. It is characterized by inflammation of the plantar fascia, a fibrous tissue which&#xD;
      connects the calcaneus to the metatarsal heads, and is often seen in individuals who are&#xD;
      overweight and/or participate frequently in weight-bearing endurance activities such as&#xD;
      running. Pain is typically at its highest during the first steps in the morning, although it&#xD;
      can also occur with prolonged weightbearing. Plantar fasciitis can be treated via&#xD;
      conservative or surgical measures, although surgery is considered as the last resort. In&#xD;
      recent years, extracorporeal shockwave therapy has emerged as an alternative conservative&#xD;
      method for treating plantar fasciitis. There are two types -- radial and focused shockwave&#xD;
      therapy. Focused therapy creates deeper-penetrating, higher-energy shockwaves, whereas radial&#xD;
      therapy produces more superficial shockwaves that can treat a wider area of pathology.&#xD;
&#xD;
      Randomized controlled trials have compared focused and radial shockwave therapy to placebo&#xD;
      and other conservative measures in the treatment of chronic plantar fasciitis and overall&#xD;
      demonstrated benefit. Only one study has directly compared radial and focused shockwave&#xD;
      therapy in this population, although pain was not an outcome of focus in the study. The&#xD;
      current study aims to collect patient-reported outcomes on both pain and function following&#xD;
      radial vs. focused shockwave therapy vs. control therapy.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2020</start_date>
  <completion_date type="Anticipated">October 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual analog scale pain - morning</measure>
    <time_frame>Up to 1 year</time_frame>
    <description>Morning pain. This will be assessed on a scale of 0-100, with a higher score representing more pain.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual analog scale pain - after prolonged walking or standing</measure>
    <time_frame>Up to 1 year</time_frame>
    <description>Pain after prolonged walking or standing. This will be assessed on a scale of 0-100, with a higher score representing more pain.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>PROMIS Physical Function computer adaptive test score</measure>
    <time_frame>Up to 1 year</time_frame>
    <description>This computer adaptive questionnaire assesses physical function. A higher score represents higher function. A score of 50 represents the population average.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Foot and Ankle Outcome Score (FAOS)</measure>
    <time_frame>Up to 1 year</time_frame>
    <description>The FAOS assess pain, symptoms, activities of daily living, sports, and quality of life related to foot and ankle pain. This will be assessed on a scale of 0-100, where 100 indicates no problems and 0 indicates extreme problems.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Treatment satisfaction</measure>
    <time_frame>Up to 1 year</time_frame>
    <description>Satisfaction with the assigned treatment will be determined on a 0-10 scale, with 10 being most satisfied and 0 being least satisfied.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">114</enrollment>
  <condition>Plantar Fascitis</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients in the control group will be treated using the home therapy protocol only.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Radial shockwave therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive 4 sessions of radial shockwave therapy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Focused shockwave therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive 4 sessions of focused shockwave therapy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Radial shockwave therapy</intervention_name>
    <description>Target intensity will be within a range of 3.5-5.0 bar at maximum Hz, titrated up to patient tolerance within 100 pulses. Total of 3000 pulses.</description>
    <arm_group_label>Radial shockwave therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Focused shockwave therapy</intervention_name>
    <description>Target intensity will be within a range of 0.15-0.25 mJ/mm2 at maximum Hz, titrated up to patient tolerance within 100 pulses. Total of 3000 pulses.</description>
    <arm_group_label>Focused shockwave therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Shockwave therapy device</intervention_name>
    <description>The shockwave therapy device will be used to administer either radial or focused shockwave therapy.</description>
    <arm_group_label>Focused shockwave therapy</arm_group_label>
    <arm_group_label>Radial shockwave therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Home therapy</intervention_name>
    <description>Stretching and ice massage</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Focused shockwave therapy</arm_group_label>
    <arm_group_label>Radial shockwave therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients presenting with a clinical diagnosis of chronic plantar fasciitis (&gt;3 months)&#xD;
             that has been recalcitrant to other treatments&#xD;
&#xD;
          -  Minimum VAS pain of 40/100 (4/10; morning pain when taking first steps, pain after&#xD;
             prolonged walking/standing)&#xD;
&#xD;
          -  English-speaking&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Cortisone injection within the past 3 months&#xD;
&#xD;
          -  Platelet-rich plasma injection within the past 6 months&#xD;
&#xD;
          -  History of previous foot surgery&#xD;
&#xD;
          -  Bilateral heel pain&#xD;
&#xD;
          -  Coagulopathies or use of anti-coagulants&#xD;
&#xD;
          -  Local and systemic neurologic or vascular insufficiencies&#xD;
&#xD;
          -  Rheumatologic disorders&#xD;
&#xD;
          -  Systemic inflammatory disorders&#xD;
&#xD;
          -  Active or chronic infection in the area&#xD;
&#xD;
          -  Lower extremity bone disorders (e.g., Paget's disease, osteomyelitis)&#xD;
&#xD;
          -  Calcaneal fractures&#xD;
&#xD;
          -  Nerve entrapment&#xD;
&#xD;
          -  Ruptures in tendon&#xD;
&#xD;
          -  Non-English speaking&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kristina Quirolgico, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital for Special Surgery, New York</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jennifer Cheng, PhD</last_name>
    <phone>6467146870</phone>
    <email>chengj@hss.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Rachel Rothman</last_name>
    <phone>2127747386</phone>
    <email>rothmanr@hss.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital for Special Surgery</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bridget Hayes</last_name>
      <phone>212-774-2056</phone>
      <email>hayesb@hss.edu</email>
    </contact>
    <investigator>
      <last_name>Kristina Quirolgico, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>March 11, 2020</study_first_submitted>
  <study_first_submitted_qc>April 1, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 2, 2020</study_first_posted>
  <last_update_submitted>September 27, 2021</last_update_submitted>
  <last_update_submitted_qc>September 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fasciitis</mesh_term>
    <mesh_term>Fasciitis, Plantar</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

